strike
preval
hiv
tb
malaria
well
outbreak
emerg
infecti
diseas
influenza
ebola
mer
pose
great
challeng
patient
care
resourcelimit
set
rl
howev
advanc
diagnost
technolog
implement
rl
larg
due
econom
constraint
simpl
inexpens
pointofcar
poc
diagnost
reli
less
environment
context
oper
train
thu
extens
studi
achiev
earli
diagnosi
treatment
monitor
nonlaboratori
set
despit
great
input
materi
scienc
biomed
engin
nanotechnolog
develop
poc
diagnost
signific
technic
challeng
yet
overcom
summar
technic
challeng
associ
poc
diagnost
rl
perspect
latest
advanc
address
challeng
review
research
point
view
homebrew
poc
assay
includ
paperbas
assay
microfluid
devic
varieti
biosensor
design
detect
quantifi
cell
virus
bacteria
protein
nucleic
acid
wang
et
al
technic
challeng
pointofcar
diagnost
infecti
diseas
resourcelimit
set
significantli
improv
health
care
reduc
diseaserel
mortal
resourcelimit
set
rl
remain
fundament
issu
despit
tremend
effort
nation
intern
level
promin
health
issu
rl
center
prevent
control
infecti
diseas
hiv
tb
malaria
well
emerg
epidem
influenza
ebola
middl
east
respiratori
syndrom
coronaviru
merscov
devast
pathogen
inflict
enorm
econom
diseas
burden
rl
also
increas
risk
worldwid
spread
diseas
date
estim
approxim
million
peopl
die
aid
million
hivinfect
individu
live
across
world
tb
malaria
togeth
coinfect
hiv
exacerb
challeng
reduc
mortal
improv
clinic
outcom
lack
function
diseas
surveil
system
rl
outbreak
influenza
ebola
merscov
caus
signific
global
concern
year
total
casesdeath
influenza
infect
report
china
hong
kong
malaysia
taiwan
canada
death
rate
outbreak
ebola
viru
diseas
evd
caus
confirm
case
result
death
west
africa
merscov
also
caus
total
case
major
saudi
arabia
republ
korea
respect
thu
health
care
system
rl
strengthen
enabl
better
diagnosi
treatment
prevent
infecti
diseas
improv
clinic
manag
infecti
diseas
individu
level
popul
level
accur
costeffect
time
diagnosi
key
given
sustain
financi
support
wellequip
laboratori
infrastructur
resourcerich
set
rr
tradit
diagnost
method
enzymelink
immunosorb
assay
elisa
cell
cultur
flow
cytometri
biopsi
polymeras
chain
reaction
pcr
sequenc
wide
implement
contrari
clinic
symptom
sign
often
use
physician
make
empir
diagnosi
minut
aid
lab
test
eg
later
flow
assay
rl
thu
leav
infect
individu
underdiagnos
andor
loss
followup
permit
diseas
transmiss
gener
popul
consid
weak
health
care
system
financi
statu
rl
pointofcar
poc
diagnost
technolog
prefer
aid
time
diagnosi
treatment
patient
primari
care
set
rapidli
provid
laboratori
evid
without
refer
sophist
laboratori
infrastructur
welltrain
oper
although
tremend
effort
made
materi
scienc
engin
nanotechnolog
toward
develop
poc
diagnost
devic
meet
criteria
poc
test
afford
sensit
specif
userfriendli
rapid
robust
equipmentfre
deliv
need
assur
variou
clinic
sampl
matric
among
develop
poc
diagnost
technolog
tabl
paperbas
assay
later
flow
strip
dipstick
wide
use
assay
clinic
simpl
work
procedur
scalabl
manufactur
capabl
low
cost
contrast
poc
diagnost
technolog
still
develop
technic
challeng
yet
overcom
clinic
valid
need
summar
technic
challeng
confront
assay
develop
review
new
research
approach
may
provid
viabl
solut
develop
qualityassur
poc
diagnost
unavail
systemat
report
poc
diagnost
industri
perspect
limit
literatur
search
poc
diagnost
infecti
diseas
pubm
web
scienc
technolog
complex
requir
assay
work
mechan
form
primari
barrier
develop
poc
diagnost
poc
test
use
clinic
need
go
follow
procedur
sampl
collect
ii
sampl
process
iii
test
andor
instrument
iv
result
analysi
data
report
v
interpret
vi
wast
dispos
procedur
form
barrier
implement
poc
test
rr
requir
laboratori
infrastructur
logist
support
readili
avail
multipl
test
procedur
howev
pose
great
technic
challeng
poc
test
rl
especi
rural
area
limit
laboratori
test
capabl
lack
skill
oper
insuffici
logist
support
rl
form
secondari
barrier
poc
test
exampl
clean
run
water
uninterrupt
electr
suppli
rural
area
clinic
sampl
collect
sampl
process
eg
centrifug
nucleic
acid
extract
instrument
nucleic
acid
assay
requir
feasibl
poc
test
cost
constraint
lack
train
personnel
reagent
need
refriger
longterm
stabil
also
challeng
poc
test
rl
anoth
import
technic
challeng
safe
dispos
biolog
wast
includ
use
diagnost
devic
clinic
sampl
rl
wast
dispos
biosafeti
stringent
regul
rr
open
air
burn
may
option
dispos
clinic
wast
medic
devic
chemic
use
poc
assay
requir
special
treatment
dispos
eg
guanidinium
thiocyan
therefor
technic
challeng
associ
technolog
complex
logist
limit
protein
nucleic
acidand
cellbas
assay
need
overcom
wide
use
rl
beyond
technic
challeng
perform
poc
test
rl
poor
clinic
perform
poc
diagnost
also
form
barrier
bring
clinic
benefit
poc
set
case
tb
test
poc
diagnost
meet
clinic
requir
convent
smear
microscopi
owe
inexpens
rapid
commonli
use
rl
howev
method
limit
low
vari
sensit
poor
detect
limit
coloni
form
unit
cfu
ml
also
morpholog
detect
mycobacterium
tuberculosi
mtb
specif
mtb
differenti
mycobacteri
strain
eg
mycobacterium
kansasii
mycobacterium
marinum
poc
test
lateralflow
base
antigenantibodi
strip
also
develop
detect
tb
serum
rl
howev
strip
suffer
low
accuraci
rapid
diagnosi
tb
anoth
type
later
flow
assay
develop
detect
lipoarabinomannan
lam
compon
mtb
cell
wall
antigen
patient
urin
sampl
although
assay
inexpens
simpletous
low
sensit
patient
posit
cultur
tb
nevertheless
assay
sensit
detect
tb
aid
patient
cell
count
may
help
manag
aidstb
coinfect
patient
subsaharan
countri
similarli
poor
clinic
perform
also
experienc
use
hiv
later
flow
strip
detect
acut
hivinfect
individu
consid
suboptim
clinic
perform
current
poc
diagnost
urgent
need
rl
nich
specif
applic
well
select
valid
particularli
remov
falseneg
falseposit
result
patient
level
requir
instrument
prove
challeng
poc
test
rl
ideal
poc
assay
reli
use
equip
rl
otherwis
cost
purchas
equip
routin
mainten
particularli
larg
equip
flow
cytomet
would
inevit
prove
financi
unsustain
technic
challeng
rl
recommend
sexual
transmit
diseas
diagnost
initi
rapid
assay
equipmentfre
poc
test
nowaday
concept
poc
test
gone
beyond
scope
rapid
later
flow
assay
especi
mainstream
develop
molecular
diagnost
devic
fast
advanc
microfluid
nanotechnolog
use
handheld
lightweight
batteryoper
instrument
gradual
becom
accept
perform
molecular
diagnosi
basic
laboratori
infrastructur
portabl
instrument
may
vari
eggbeat
solar
panel
smart
phone
without
addon
modal
although
poc
assay
equipmentfre
implement
nonlaboratori
set
basic
logist
support
anoth
import
technic
challeng
often
neglect
poc
assay
develop
userinterfac
howev
good
assay
result
simpletounderstand
easili
interpret
lessskil
health
care
worker
rl
even
patient
homeset
instanc
glucos
meter
one
repres
exampl
success
poc
assay
market
userinterfac
glucos
meter
improv
ad
resultread
capabl
signific
portion
diabet
patient
elderli
andor
visionimpair
audio
report
test
result
speaker
elimin
visual
difficulti
read
test
result
also
increas
likelihood
patient
adher
glucos
selfmonitor
anoth
exampl
recent
develop
blood
type
use
paperbas
devic
term
group
legibl
immunohematolog
format
glif
card
improv
userinterfac
assay
result
selfinterpret
show
b
devic
blood
type
b
respect
thu
endus
would
readili
understand
result
without
interpret
health
care
worker
permit
selftest
rl
howev
assay
equip
good
assay
interfac
endus
vari
level
technic
train
improv
upcom
poc
assay
proteinbas
poc
assay
common
assay
develop
use
clinic
gener
protein
either
antigen
antibodi
easili
immobil
paper
surfac
well
surfac
microfluid
devic
polystyren
bead
magnet
bead
varieti
surfac
chemistri
approach
wellknown
assay
format
later
flow
assay
agglutin
assay
dipstick
assay
use
detect
biomark
infecti
diseas
cancer
noncommunic
diseas
eg
cardiovascular
diseas
despit
wide
applic
clinic
proteinbas
poc
assay
suffer
unsatisfactori
sensit
batchtobatch
variat
low
multiplex
capabl
subject
result
interpret
addit
proper
select
antibodyantigen
pair
timeconsum
laborintens
costli
assay
develop
detect
limit
proteinbas
poc
assay
improv
signal
amplif
protein
enrich
use
sensit
signal
agent
fluoresc
dye
andor
sensit
detect
mechan
strategi
signal
amplif
util
biotinstreptavidin
approach
withwithout
enzymat
reaction
caution
background
nois
may
also
enhanc
along
target
signal
therefor
approach
necessarili
increas
signalnois
ratio
microtipbas
system
develop
enrich
concentr
mtb
electroosmosi
coupl
fluoresc
label
method
detect
mtb
cell
low
cfuml
within
min
although
method
sensit
enough
poc
test
method
coupl
detect
strategi
eg
nucleic
acid
amplif
method
improv
anoth
approach
enhanc
detect
limit
later
flow
assay
use
fluoresc
detect
replac
gold
nanoparticl
agglutinationinduc
visual
nake
eye
although
approach
increas
detect
limit
nucleic
acid
compar
tradit
later
flow
strip
fluoresc
reader
need
make
less
suitabl
use
rl
recent
local
surfac
plasmon
reson
lspr
figur
giant
magnetoresist
gmr
sensor
develop
sensit
detect
low
concentr
protein
biotarget
biolog
sampl
indic
ultrasensit
detect
strategi
may
provid
solut
significantli
improv
detect
limit
poc
assay
provid
made
portabl
inexpens
enhanc
multiplex
capabl
poc
assay
microfluid
devic
introduc
multipl
branch
built
singl
microfluid
devic
multiplex
capabilha
significantli
enhanc
recent
report
ligand
specif
target
separ
immobil
individu
channel
markedli
reduc
consumpt
biologisampl
approach
multiplex
immobil
multipl
reagent
differ
spot
singl
microchannel
exampl
simultan
detect
hiv
syphili
elisa
achiev
microfluid
devic
term
mchip
poc
test
rwanda
figur
besid
microfluid
devic
multiplex
capabl
poc
assay
expand
paper
includ
paper
microfluid
vertic
flow
array
paper
microfluidicsbas
approach
paper
engin
hydrophil
channel
direct
fluid
flow
multipl
spot
differ
detect
ligand
immobil
microfluid
paperbas
analyt
devic
develop
whitesid
group
enhanc
multiplex
capabl
low
cost
demonstr
paperbas
test
measur
aspart
aminotransferas
ast
alanin
aminotransferas
alt
detect
drugrel
hepatotox
rl
figur
vertic
flow
array
anoth
attract
approach
multiplex
far
demonstr
assay
format
use
simultan
measur
ige
reactiv
allergen
array
format
approach
enhanc
multiplex
capabl
also
elimin
interfer
detect
multipl
target
array
signific
problem
seen
later
flow
assay
downstream
effect
poc
assay
colorimetr
detect
often
use
may
result
subject
result
recognit
interpret
issu
recent
resolv
use
portabl
reader
develop
mobil
app
analyz
result
object
addit
portabl
reader
detect
dubiou
result
discrimin
much
higher
resolut
compar
nake
eye
recent
integr
cell
phone
base
colorimetr
detect
onchip
elisa
develop
earli
ovarian
cancer
detect
urin
figur
clinic
valid
show
assay
sensit
specif
thu
introduct
portabl
reader
potenti
increas
sensit
accuraci
quantif
semiquantif
two
technic
challeng
associ
proteinbas
poc
assay
proper
antigenantibodi
select
batchtobatch
variat
assay
develop
manufactur
improv
sensit
specif
care
ass
antigenantibodi
reaction
import
whether
need
monoclon
antibodi
assay
need
evalu
differ
monoclon
antibodi
differ
epitop
well
balanc
cost
complex
particularli
multiplex
test
crossreact
unpair
antigenantibodi
avoid
stringent
assess
despit
care
select
antigenantibodi
pair
assay
develop
antibodi
gradual
lose
immunoaffin
differ
passag
antibodyproduct
cell
largescal
product
batchtobatch
variat
minim
appropri
qualiti
control
qualiti
assur
method
nucleic
acidbas
poc
assay
extens
explor
last
decad
signific
drive
detect
virus
bacteria
nonlaboratori
set
one
strike
need
develop
hiv
viral
load
test
directli
measur
number
circul
hiv
virion
monitor
antiretrovir
therapi
art
aid
patient
rl
although
sever
nucleic
acid
amplif
test
nat
approach
design
aid
art
monitor
technolog
complex
expens
limit
use
wellequip
laboratori
skill
oper
recent
consider
advanc
develop
fieldimplement
instrument
measur
hiv
viral
load
rl
howev
technic
challeng
sampl
collectionsampl
process
nucleic
acid
extract
amplif
instrument
still
remain
challeng
discuss
also
occur
natbas
poc
applic
sampl
collectionprocess
primari
step
nat
bottleneck
poc
gener
plasma
sampl
need
presenc
blood
cell
interfer
downstream
nucleic
acid
amplif
exampl
report
presenc
hemin
hemoglobin
nucleic
acid
extract
inhibit
amplif
effici
pcr
thu
method
rapidli
isol
plasma
unprocess
whole
blood
would
welcom
natbas
poc
applic
number
studi
report
plasma
separ
base
mechan
sizeexclus
hydrodynam
forc
microchannel
geometri
although
approach
extract
plasma
unprocess
whole
blood
without
use
centrifug
still
suffer
use
extern
instrument
either
pump
vacuum
lowvolum
blood
process
hemolysi
dilut
blood
cell
contamin
altern
dri
blood
spot
db
use
substrat
collect
blood
sampl
rl
transfer
wellresourc
laboratori
howev
approach
solv
sampl
process
issu
face
fieldtest
type
clinic
sampl
matric
eg
sputum
tb
nasopharyng
swab
sampl
influenza
also
present
signific
challeng
field
sampl
process
prior
nat
rl
nucleic
acid
extract
anoth
signific
challeng
perform
nat
poc
gold
standard
method
nucleic
acid
extract
develop
boom
et
al
use
chaotrop
agent
approach
requir
multipl
load
step
reagent
centrifug
spin
column
subsequ
wash
step
although
sever
type
autom
nucleic
acid
extract
instrument
commerci
avail
challeng
adapt
instrument
poc
test
costeffect
manner
new
method
nucleic
acid
extract
creat
temporari
paper
fluidic
circuit
complex
chemic
sequenti
process
fold
unfold
surfac
although
microfluid
origami
devic
rapid
min
method
may
applic
heat
need
nucleic
acid
extract
addit
effici
extract
target
nucleic
acid
compar
gold
standard
still
requir
verif
anoth
paperbas
nucleic
acid
extract
approach
recent
report
detect
influenza
human
nasopharyng
specimen
method
piec
poli
ether
sulfon
pe
filter
paper
attach
cellulos
absorb
pad
capillari
forc
movement
sampl
figur
nucleic
acid
extract
nasopharyng
specimen
lyse
ad
pe
filter
paper
influenza
rna
isol
pe
filter
paper
subsequ
purifi
rins
ethanol
extract
method
easi
rapid
provid
centrifugationfre
method
nucleic
acid
extract
outsid
laboratori
set
demonstr
coupl
loopmedi
isotherm
amplif
lamp
later
flow
strip
amplif
detect
respect
nucleic
acid
amplifi
certain
enzym
set
enzym
isotherm
eg
nucleic
acid
sequenc
base
amplif
nasba
recombinas
polymeras
amplif
rpa
lamp
temperatur
cycl
ie
pcr
either
way
temperatur
control
critic
ensur
amplif
effici
accuraci
howev
control
temperatur
precis
degre
prove
challeng
rl
given
lack
stabl
electr
suppli
therefor
isotherm
amplif
often
use
pcr
perform
nat
poc
elimin
rapid
cycl
heat
cool
reduceelimin
power
consumpt
associ
thermal
cycl
isotherm
amplif
chemic
heat
approach
develop
approach
exotherm
reaction
calcium
oxid
water
use
gener
heat
figur
engin
phase
chang
materi
use
buffer
temperatur
approxim
isotherm
amplif
hiv
rtlamp
noninstru
nucleic
acid
nina
heater
develop
ad
thermal
insul
stainlesssteel
canist
plastic
screwtop
lid
allow
three
amplif
reaction
run
simultan
simpl
electricityfre
heat
instrument
amplif
hiv
rna
made
possibl
facilit
rna
test
rl
consid
lack
stabl
power
suppli
rl
electricityfre
approach
may
provid
gener
practic
temperatur
control
isotherm
amplif
microfluid
pcr
continu
flow
design
recent
solar
heat
system
develop
provid
electr
pcr
amplif
gener
energyintens
rapid
thermal
cycl
method
solar
panel
convert
sunlight
heat
provid
energi
maintain
three
temperatur
zone
denatur
anneal
extens
design
sunlight
focus
len
pass
ringshap
mask
convert
heat
absorb
layer
figur
continuousflow
microfluid
pcr
chip
design
pass
sampl
three
temperatur
zone
cycl
precis
control
desir
temperatur
chip
three
thermocoupl
connect
microcontrol
mobil
app
develop
report
author
demonstr
solar
pcr
amplifi
kaposi
sarcoma
herp
viru
dna
within
min
power
consumpt
reduc
compar
tradit
thermal
cycler
sinc
sunlight
ubiquit
solar
pcr
system
show
great
potenti
perform
molecular
diagnosi
electr
limit
import
challeng
develop
nucleic
acidbas
poc
assay
integr
autom
differ
assay
modul
standalon
system
attempt
develop
fulli
integr
system
molecular
diagnosi
poc
exampl
fluorescencebas
sampletoansw
quantit
pcr
qpcr
system
figur
develop
detect
provir
dna
infant
poc
aim
earli
diagnosi
requir
reagent
freezedri
store
dispos
card
facilit
pcr
batteryoper
benchtop
pcr
instrument
develop
contain
three
modul
electromechan
reagent
deliveri
erd
thermal
cycl
fluoresc
detect
proofofconcept
system
detect
hiv
provir
dna
level
copi
per
reaction
still
need
improv
better
sensit
addit
system
could
test
singl
sampl
suffer
low
throughput
make
impract
use
clinic
although
system
batteryoper
portabl
still
technolog
complex
use
poc
test
rl
signific
improv
molecular
diagnost
technolog
develop
genexpert
platform
cepheid
platform
abl
autom
entir
process
requir
sampl
process
nucleic
acid
extract
amplif
detect
offer
samplein
answerout
solut
ideal
endus
demonstr
far
platform
detect
mtb
resist
rifampin
untreat
sputum
sampl
h
detect
mtb
cultureposit
patient
platform
sensit
specif
detect
rifampin
resist
platform
sensit
compar
phenotyp
drugsuscept
test
howev
system
wide
adopt
poc
test
rl
still
rel
expens
instrument
dispos
devic
mainten
requir
stabl
power
consumpt
rel
long
turnaround
time
thu
develop
ideal
poc
nat
platform
yet
remain
unaddress
technic
challeng
cellbas
assay
complex
gener
use
poc
test
howev
exampl
cellbas
poc
assay
design
develop
tackl
global
health
challeng
eg
cell
count
malaria
detect
cell
count
import
initi
art
aid
patient
within
global
context
expand
art
rl
varieti
portabl
cell
count
approach
develop
base
simplifi
flow
cytometri
fluoresc
stain
electr
sens
lensless
imag
centrifugationinduc
condens
microafluid
elisa
simplifi
flow
cytomet
facscount
becton
dickinson
franklin
lake
nj
usa
guava
san
francisco
ca
usa
cyflow
partec
jettingenscheppach
bavaria
germani
panleucog
beckman
coulter
kraember
blvd
brea
ca
usa
provid
reliabl
result
compar
facscalibur
gold
standard
method
measur
cell
count
howev
still
need
rel
expens
equip
instrument
mainten
adequ
oper
train
limit
widespread
use
rl
pima
portabl
fluoresc
cell
count
aler
test
multisit
multicent
evalu
show
pima
suitabl
identifi
adult
aid
patient
elig
art
monitor
efficaci
neg
underestim
seen
fingerprick
versu
venou
blood
use
pima
need
basic
laboratori
infrastructur
run
fluoresc
imag
preclud
pima
use
lower
tier
laboratori
rl
addit
note
accuraci
pima
affect
critic
variabl
step
capillari
sampl
three
proofofconcept
cellbas
poc
assay
develop
aim
provid
simpl
inexpens
rapid
solut
initi
monitor
cell
count
aid
patient
rl
first
lensless
imag
techniqu
coupl
microfluid
show
feasibl
count
cell
immunecaptur
unprocess
whole
blood
immuneaffin
antibodi
imag
setup
simpl
use
inexpens
ccd
shadow
imag
captur
cell
process
use
imagej
rapidli
provid
cell
count
fieldtest
show
method
easytous
perform
local
health
care
worker
minimum
train
second
microafluid
devic
develop
magnet
bead
cell
captur
specif
antibodi
entir
test
process
autom
portabl
lightweight
inexpens
instrument
third
centrifugebas
approach
develop
condens
cell
label
heavi
microparticl
microcapillari
column
height
label
cell
column
correl
number
cell
whole
blood
provid
attract
method
guid
art
rl
howev
three
method
need
multisit
clinic
trial
assess
sensit
specif
accuraci
precis
recent
magnet
suscept
cell
util
achiev
cellbas
test
poc
known
plasmodium
sppinfect
red
blood
cell
rbc
increas
paramagnet
suscept
malaria
parasit
convert
hemoglobin
hemozoin
crystallit
inexpens
benchtop
mrr
system
develop
detect
hemozoin
particl
rbc
detect
limit
volum
ml
whole
blood
within
minut
author
overcam
fluctuat
mrr
baselin
among
individu
establish
baselin
mrr
togeth
microfluidicbas
cell
enrich
approach
figur
author
detect
low
ring
stage
parasit
method
requir
minim
sampl
process
step
chemic
immunolabel
make
attract
rapid
malaria
diagnosi
rl
densitybas
devic
develop
detect
sickl
cell
diseas
scd
use
aqueou
polym
mixtur
dens
cell
visual
centrifug
figur
although
method
sensit
inexpens
method
may
suffer
lack
gener
cell
densiti
confirm
scd
anoth
approach
term
magnet
levit
recent
report
detect
cancer
cell
whole
blood
differenti
sickl
rbc
healthi
rbc
uniqu
levit
profil
differ
cell
type
author
differenti
breast
esophag
colorect
nonsmal
cell
lung
cancer
cell
line
spike
whole
blood
rapid
method
requir
electr
labelfre
inexpens
easytous
show
great
promis
cancer
detect
poc
nevertheless
magnet
susceptibilitybas
approach
need
clinic
trial
valid
current
approv
use
rl
poc
diagnost
play
central
role
confirm
clinic
diagnosi
monitor
treatment
predict
prognosi
clinic
well
diseas
surveil
larg
popul
level
rl
poc
assay
critic
may
diagnost
option
onsit
help
physician
patient
care
diseas
manag
howev
singl
poc
technolog
far
detect
biomark
nucleic
acid
antigen
antibodi
etc
effici
specif
without
clinic
constraint
nevertheless
multipl
approach
develop
specif
tackl
technic
challeng
associ
protein
nucleic
acidand
cellbas
poc
assay
therefor
envis
joint
effort
multidisciplinari
field
clinician
biologist
engin
fulli
integr
assay
would
eventu
appear
enabl
much
need
poc
test
particularli
rl
develop
poc
assay
rl
would
seem
simpl
task
use
lowcost
materi
lowend
technolog
practic
opposit
complet
task
requir
multidisciplinari
expertis
materi
scienc
hardwar
softwar
engin
immunolog
molecular
biolog
medicin
also
appreci
regul
cultur
polici
rl
task
daunt
need
develop
highend
clinic
diagnost
assay
limit
budget
strict
oper
requir
suboptim
condit
therefor
much
challeng
develop
poc
assay
rl
rather
establish
sophist
protocol
highend
diagnost
technolog
rr
work
challeng
would
highli
reward
imagin
deliv
practic
poc
assay
save
live
treat
patient
prevent
diseas
rl
need
much
higher
diseas
burden
locat
must
divid
context
poc
diagnost
differ
test
scenario
conquer
specif
challeng
assay
develop
discuss
earlier
mani
technic
challeng
need
address
success
develop
poc
assay
rl
howev
need
divid
technic
challeng
associ
differ
tier
level
poc
scenario
tabl
rl
consider
variat
term
diagnost
capabl
patient
care
rl
first
tier
nation
refer
laboratori
stateoftheart
diagnost
technolog
welltrain
technician
sophist
laboratori
infrastructur
capac
perform
elisa
pcr
flow
cytometri
cell
cultur
dna
sequenc
secondti
region
laboratori
may
limit
access
diagnost
capabl
lesstrain
personnel
financi
support
gener
equip
light
microscop
spectrophotomet
basic
laboratori
infrastructur
benchtop
centrifug
heater
refriger
also
limit
capabl
perform
immunoassay
blood
chemistri
bacteri
cultur
thirdtier
district
laboratori
may
exist
communitybas
hospit
gener
diagnost
capabl
except
later
flow
assay
agglutin
assay
rural
area
hospit
laboratori
clean
water
even
reliabl
power
suppli
patient
seen
health
care
worker
littl
formal
medic
train
laboratori
train
train
thousand
front
line
health
worker
use
poc
devic
trivial
task
either
clearli
singl
test
meet
distinct
level
clinic
need
differ
poc
scenario
vari
diagnost
capac
therefor
need
divid
defin
technic
challeng
associ
poc
assay
develop
conquer
right
context
overcom
technic
challeng
barrier
also
need
smoothli
remov
barrier
includ
limit
transcontinent
collabor
conflict
intellectu
properti
share
lack
fund
mechan
identifi
intern
workshop
next
gener
poc
diagnost
addit
poc
assay
develop
need
appreci
technic
challeng
ground
exampl
academ
laboratori
student
postdoc
work
poc
assay
develop
littl
idea
real
situat
rl
use
instrument
fluoresc
sophist
optic
detect
mechan
harsh
chemic
reagent
short
shelflif
would
fit
poc
test
rl
furthermor
strong
collabor
academ
industri
need
place
diagnost
product
pipelin
poc
assay
develop
academ
laboratori
lack
qualiti
control
qualiti
assur
develop
proofofconcept
diagnost
technolog
result
reproduc
accuraci
precis
develop
diagnost
technolog
fieldtest
often
compromis
strong
collabor
industrycompani
partner
appreci
need
ground
academ
laboratori
would
equip
capabl
tackl
mani
technic
challeng
poc
diagnost
technolog
bypass
valley
death
eventu
reach
market
mobilebas
poc
diagnost
mhealth
rapidli
explor
provid
health
care
monitor
develop
smartphon
owe
portabl
builtin
sensor
data
transferprocess
capabl
use
measur
heart
rate
breath
rate
blood
pressur
well
dissemin
health
inform
addit
smartphon
coupl
miniatur
microfluid
devic
rapid
data
collect
result
analysi
vitro
diagnosi
wearabl
devic
wirelessli
connect
smartphon
realtim
monitor
health
condit
treatment
efficaci
decreas
price
smartphon
mhealthbas
approach
significantli
reduc
equip
requir
implement
poc
assay
rl
next
year
innov
technolog
made
address
challeng
associ
poc
diagnost
rl
proteinbas
poc
diagnost
new
poc
diagnost
design
frame
assur
guidelin
would
appear
particularli
userinterfac
diagnost
endus
significantli
simplifi
appreci
test
result
thu
enhanc
accept
proteinbas
poc
diagnost
also
low
sensit
limit
multiplex
capabl
proteinbas
poc
diagnost
improv
level
benchmark
assay
typic
perform
hospit
set
nucleic
acidbas
cellbas
poc
assay
handheld
batteryoper
inexpens
instrument
would
accept
poc
test
rl
natur
technolog
complex
multistep
procedur
celland
nucleic
acidbas
poc
assay
full
integr
sampl
collect
data
report
would
realiz
entir
process
would
autom
maximum
degre
littl
handson
requir
endus
cost
would
still
issu
debat
develop
poc
assay
would
primari
constraint
technolog
innov
wit
signific
cost
reduct
sequenc
technolog
ideal
poc
assay
regardless
detect
protein
nucleic
acid
cell
would
appear
practic
aid
control
prevent
infecti
diseas
onsit
rl
technic
challeng
poc
diagnost
need
divid
defin
accord
specif
requir
clinic
need
oper
condit
address
right
context
low
sensit
limit
multiplex
capabl
proteinbas
poc
diagnost
technolog
improv
accommod
clinic
need
rl
assur
guidelin
sampletoansw
capabl
achiev
nucleic
acidand
cellbas
poc
assay
aid
inexpens
portabl
batteryoper
instrument
streamlin
translat
rl
joint
effort
interdisciplinari
research
materi
scienc
biomed
engin
comput
scienc
well
collabor
industri
urgent
need
synergist
speed
develop
poc
diagnost
cell
phone
increasingli
integr
poc
diagnost
assay
develop
data
collect
analysi
report
document
widespread
use
rl
new
approach
address
technic
challeng
associ
proteinbas
poc
test
resourcelimit
set
ultrasensit
detect
biotarget
use
nanoplasmon
detect
platform
b
simultan
detect
syphili
microfluid
devic
imag
adapt
permiss
c
liver
function
test
imag
adapt
permiss
cell
phonebas
colorimetr
detect
ovarian
cancer
urin
onchip
brief
introduct
poc
test
platform
dipstick
dipstick
tradit
design
detectmeasur
target
immers
urin
dipstick
also
use
detect
target
small
volum
liquid
flow
liquid
along
dipstick
later
flow
test
later
flow
test
known
later
flow
liquid
immunochromatograph
devic
detect
target
analyt
clinic
sampl
matrix
without
need
special
costli
equip
vertic
flow
test
vertic
flow
test
commonli
use
array
detect
multipl
target
liquid
includ
sampl
reagent
flow
array
aid
vacuum
pump
vertic
flow
array
new
class
microfluid
devic
use
paper
substrat
contain
microchannel
direct
fluidic
flow
desir
pattern
microfluid
microfluid
liter
mean
studi
small
volum
liquid
scale
submillimet
interfac
physic
chemistri
nanotechnolog
biotechnolog
engin
poc
test
microfluid
devic
use
detect
biomark
small
volum
sampl
high
sensit
specif
nanotechnolog
nanotechnolog
broad
research
domain
interest
particularli
matter
dimens
rang
nm
poc
test
gold
nanoparticl
wide
use
eg
later
flow
strip
tabl
technic
challeng
poc
test
differ
lab
set
rl
